In a Wuhan study of 240 patients with pneumonia, half received favipiravir and the other half umifenovir.
Katika utafiti uliofanywa huko Wuhan kwa wagonjwa 240 wenye ugonjwa wa nimonia, nusu yao walipewa favipiravir na nusu walipewa umifenovir.